Phase I Trial of an Alhydrogel Adjuvanted Hepatitis B Core Virus-Like Particle Containing Epitopes of Plasmodium falciparum Circumsporozoite Protein

• Aric L. Gregson,

  Current address: Division of Infectious Diseases, Department of Medicine, University of California Los Angeles, Los Angeles, California, United States of America,

  Affiliation Department of Medicine and Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Giane Oliveira,

  Current address: Regeneron Pharmaceuticals, Inc., Tarrytown, New York, United States of America

  Affiliation Department of Medical and Molecular Parasitology, New York University School of Medicine, New York, New York, United States of America

  ⨯
• Caroline Othoro,

  Affiliation Department of Medical and Molecular Parasitology, New York University School of Medicine, New York, New York, United States of America

  ⨯
• J. Mauricio Calvo-Calle,

  Current address: Department of Pathology, University of Massachusetts School of Medicine, Worcester, Massachusetts, United States of America

  Affiliation Department of Medical and Molecular Parasitology, New York University School of Medicine, New York, New York, United States of America

  ⨯
• George B. Thorton,

  Affiliation Apovia, Inc., San Diego, California, United States of America

  ⨯
• Elizabeth Nardin,

  Affiliation Department of Medical and Molecular Parasitology, New York University School of Medicine, New York, New York, United States of America

  ⨯
• Robert Edelman

  *E-mail: redelman@medicine.umaryland.edu.

  Affiliation Department of Medicine and Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯